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Clues from the kidneys: Case report on end-stage pulmonary fibrosis 
Abrill Jones, M.D. 
Diagnostic Assessment 
Discussion 
Follow-up and Outcomes 
Therapeutic Intervention 
The patient’s diagnosis upon biopsy is revealed to 
be Granulomatosis with polyangiitis (GPA), 
previously known as Wegener’s granulomatosis. 
An antineutrophil cytoplasmic antibodies (ANCA)-
associated small-vessel vasculitides (AAV) that 
typically presents between the ages of 35-55 years 
old. In the United States it has a prevalence of 3 
out of every 100,000 people. It is more common in 
those of northern European descent (around 90%), 
particularly males (male-to-female ratio of 1:1.5). 
The decision to perform a renal biopsy on this 
patient was secondary to the presentation of acute 
renal failure in the background of end-stage 
pulmonary fibrosis. The biopsy and diagnosis did 
not occur in time to save this patient from end-
organ damage. The presentation of the pulmonary 
fibrosis so far in advance of the renal failure and 
without other features, such as sinus and/or oral  
cavity involvement. In future patients with interstitial 
lung disease without an identified potential cause, 
one could consider performing serology for specific 
connective tissue diseases and/or biopsy of skin, 
sinus/nasal septum, muscle or kidney. 
Renal biopsy showing diffuse sclerosing, focal necrotizing, & 
crescentic glomerulonephritis, pauci-immune type, acute & 
chronic, severe (P-ANCA associated). Chronic & 
granulomatous interstitial inflammation, diffuse & severe. 
Tubular atrophy & interstitial fibrosis, moderate to severe. 
Arteriosclerosis, moderate. 
Lab  Result on 
First Lab 
Draw 
Result on 
discharge  or 
follow-up 
Hemoglobin (13.0-17.2) 8.4 13.3 
Creatinine 9.60 3.70 
Estimated Glomerular 
Filtration Rate 
6 18 
MPO Antibodies 
(0.0-0.9)* 
40.2 <9.0 (~1 month 
later) 
ANCA-Perinuclear (P-ANCA) 
(Neg:<1:20) titer 
1:160 <1:20 (~1 month 
later) 
BMI 15.78 17.81 (~1 month 
later) 
Solu-Medrol Plasmaphoresis Cyclophosphamide 
Posterior Anterior  chest x-ray: Diffuse interstitial opacity and 
fibrotic changes consistent with pulmonary fibrosis. 
A 49-year old Hispanic male with a 9-year history of 
pulmonary fibrosis of unknown etiology (now end-stage 
and referred for lung transplant) is advised to go to the 
emergency department (ED) by his primary care 
physician for an elevated Creatinine of 8.9 and blood 
urea nitrogen (BUN) of 89 on out-patient testing. Upon 
presenting  to the ED, laboratory testing reveals the 
patient’s Cr to be 9.6 and BUN is 96.  
When the patient was examined he was found to be 
cachectic in appearance with temporal wasting and 
atrophied extremities (but able to ambulate). He was 
tachycardic with a heart rate of 110 at rest and had an 
oxygen saturation of 92-93% on room air. 
* Myeloperoxidase + Proteinase 3 
•2 more doses of cyclophosphamide administered.  
•Placement of arteriovenous fistula for dialysis  
performed. 
• MPO and P-ANCA continued to be negative 
through repeat testing. 
Author of this slide is unknown 
Patient Information 
9 years ago: CT scan shows scattered interstitial areas of 
abnormality peripherally in both lower lobes, lateral aspect of 
both middle lobes and also in both upper lobes consistent with 
interstitial lung fibrosis.  
6 years ago: Patient visits his pulmonologist. His CT scan 
shows scattered peripheral subpleural reticular opacities and 
subpleural regions of honeycombing with mid-to-lung 
predominance with mild ground-glass attenuation at the bases.  
The patient decides to try a course of alternative medicine.   
5 months prior to current admission: Pt is admitted with Acute 
on chronic hypoxic respiratory failure with worsening  idiopathic 
pulmonary fibrosis (PaO2 55% on room air). No infectious cause 
found (Ziehl-Neelson stain negative for acid-fast organisms and 
QuantiFeron was within normal limits. Cultures are also 
negative). Patient is placed on home O2 and referred for 
possible lung transplant. 
This admission: Pt admitted with Acute Renal Failure, anemia 
(likely secondary to renal failure, pulmonary fibrosis and weight 
loss.  
Differential Diagnoses: Myeloma, Pulmonary fibrosis 
secondary to bird exposures, Alpha-1 antitrypsin deficiency, 
Hepatitis B & C, HIV 
 
Timeline 
Follow Up Care 
